• Founded: 2020
  • Location: Boston, MA
  • Employee range: 1 - 10
  • Clinical stage: RD
  • Product link: https://www.76bio.com/



job board

Short description:

Targeted Protein Degraders

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

76Bio, founded in 2020, is developing therapies that target unnecessary proteins for degradation in treatment of various life-threatening diseases. The team has backgrounds in immunology, oncology, biology, and genetics. CEO, Christopher Wilfong, previously co-founded and held leadership positions at other Two River companies, including Kite Pharma, Kronos Bio, and Neogene Therapeutics. 76Bio’s R&D headquarters is located in Boston, MA.


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com